Comment on: Tenofovir DF/emtricitabine/rilpivirine as HIV post-exposure prophylaxis: results from a multicentre prospective study
2019 ◽
Vol 74
(11)
◽
pp. 3402-3403
◽
2019 ◽
Vol 74
(4)
◽
pp. 1021-1027
◽
2020 ◽
Vol 7
(Supplement_1)
◽
pp. S521-S522